The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Hydroxy-4-(2-benzyloxyacridin-9-ylamino)benzamide ID: ALA4761847
PubChem CID: 162659066
Max Phase: Preclinical
Molecular Formula: C27H21N3O3
Molecular Weight: 435.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1
Standard InChI: InChI=1S/C27H21N3O3/c31-27(30-32)19-10-12-20(13-11-19)28-26-22-8-4-5-9-24(22)29-25-15-14-21(16-23(25)26)33-17-18-6-2-1-3-7-18/h1-16,32H,17H2,(H,28,29)(H,30,31)
Standard InChI Key: QJZZSSBITISGGT-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
10.1431 -16.7050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4342 -16.2984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4318 -15.4812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1383 -15.0706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8472 -15.4771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8496 -16.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4390 -17.9328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4390 -18.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1443 -19.1545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1443 -17.5201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8495 -17.9328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8506 -18.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5549 -19.1554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5528 -17.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2616 -17.9310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2665 -18.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9743 -19.1533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6820 -18.7418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6771 -17.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9647 -17.5150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5506 -16.7039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2572 -16.2934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9671 -16.7022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6716 -16.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6736 -15.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9650 -15.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2543 -15.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3818 -15.0698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0891 -15.4792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3827 -14.2526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0909 -13.8448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7301 -17.5263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7277 -16.7091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
7 8 2 0
7 10 1 0
8 9 1 0
9 12 2 0
11 10 2 0
11 12 1 0
11 14 1 0
12 13 1 0
13 16 2 0
15 14 2 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
14 21 1 0
21 22 1 0
22 23 2 0
22 27 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
25 28 1 0
28 29 2 0
28 30 1 0
30 31 1 0
7 32 1 0
32 33 1 0
33 2 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.48Molecular Weight (Monoisotopic): 435.1583AlogP: 5.83#Rotatable Bonds: 6Polar Surface Area: 83.48Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.31CX Basic pKa: 8.41CX LogP: 5.05CX LogD: 4.34Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.18Np Likeness Score: -0.79
References 1. Tseng HJ,Lin MH,Shiao YJ,Yang YC,Chu JC,Chen CY,Chen YY,Lin TE,Su CJ,Pan SL,Chen LC,Wang CY,Hsu KC,Huang WJ. (2020) Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease., 192 [PMID:32151835 ] [10.1016/j.ejmech.2020.112193 ]